Navigation Links
New Atrial Fibrillation Surgery Improves Results

Called a 'box lesion,' it helps isolate electrical impulses causing irregular heartbeat

MONDAY, April 21 (HealthDay News) -- Adding one step and no more than 20 seconds to heart surgery can greatly improve the results of an operation to treat the common irregular heartbeat called atrial fibrillation, according to a new report.

In the April issue of the Journal of Thoracic and Cardiovascular Surgery, heart surgeons at Washington University School of Medicine in St. Louis reported that one extra ablation -- a precise scar that destroys the heart muscle tissue housing the short circuit responsible for the irregular heartbeat -- to a series of such scars already being made during the surgery makes a significant difference.

"The single additional ablation creates what we call a box lesion," Dr. Ralph J. Damiano Jr., the John Shoenberg Professor of Surgery at the Washington University School of Medicine, said in a prepared statement. "The box lesion surrounds and electrically isolates the pulmonary veins and the posterior left atrial wall from the rest of the left atrium. Our study shows excellent success when using the box lesion, and we recommend it for any patient with long-standing atrial fibrillation."

During atrial fibrillation, the upper chambers (atria) of the heart beat rapidly and quiver instead of contracting, drastically reducing the amount of blood they pump. Without the box lesion, this area could still conduct electrical signals that disrupt the regular contractions of the heart's upper chambers.

The extra ablation improves upon the Cox-Maze procedure, a surgical procedure that redirects wayward electrical impulses causing irregular heartbeat. The procedure, which creates a series of ablations in the heart muscle, is highly effective at curing atrial fibrillation, the Washington University scientists said.

The study involved two groups of patients undergoing surgery to correct atrial fibrillation -- one receiving Cox-Maze procedures with a box lesion and one without it. The box lesion group had a 48 percent lower occurrence of atrial flutter and fibrillation in the first weeks following surgery. These patients also had shorter hospital stays -- nine days on average versus 11 days.

Three months after surgery, only 5 percent of patients with the box lesion showed signs of atrial fibrillation, compared with 15 percent of the patients receiving the standard procedure. All patients in the box lesion group were free from atrial fibrillation after six months, compared with 90 percent of the other group, the researchers said.

More than 2 million people in the United States have atrial fibrillation, which can cause fatigue, shortness of breath, heart palpitations and stroke. Medications can control the abnormal heart rhythms in some patients, as well as the risk of clotting, but only surgery can cure the disorder.

More information

The American Heart Association has more about atrial fibrillation.

-- Kevin McKeever

SOURCE: Washington University in St. Louis, news release, April 7, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
2. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
3. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
4. Atrial Fibrillation Screening Can Identify Irregular Heartbeat That Leads to Stroke
5. FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
6. CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
7. St. Davids Medical Center First in Texas to Implement Visually Guided Catheter Ablation for Atrial Fibrillation
8. Surgeons announce advance in atrial fibrillation surgery
9. Defibrillation Comes Late in 30 Percent of Hospital Cases
10. For hospital patients, defibrillation delays mean lower survival
11. One Surgery Often Enough for Peritonitis
Post Your Comments:
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... It’s ... has a tattoo — a number even greater among Millennials (a whopping one in ... are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... 01, 2015 , ... The importance of volumetric breast density ... of numerous abstracts accepted for presentation here, at the 101st Annual Radiology Society ... the use of Volpara Solutions’ quantitative breast imaging software tools for providing breast ...
(Date:12/1/2015)... Diego, CA (PRWEB) , ... December 01, 2015 ... ... and scale , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro ... mobile imaging results enhancements at the Radiological Society of North America (RSNA) 2015 ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... it has been awarded a fixed price per sprint agile development contract to ... at $34 million over five years, provides software engineering, infrastructure, as well as ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015  Six months of adjunctive metformin therapy ... 1 diabetes, according to new research from T1D Exchange ... may have a beneficial effect on measures of obesity, including ... of the Journal of the American Medical Association , ... effect of metformin on overweight and obese adolescents with type ...
(Date:12/1/2015)... 1, 2015 During the recent 2015 ... San Francisco, CA , Medinol Ltd. continued ... marketplace. During a satellite symposium, "The BioNIR eDES: ... Minimize Restenosis", a renowned physician panel discussed the ... CoCr Coronary Stent System and the Medinol eDES ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
Breaking Medicine Technology: